Eqis Capital Management, Inc. Twist Bioscience Corp Transaction History

Eqis Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$26.2 - $54.0 $120,808 - $248,994	-4,611 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$38.58 - $83.27 $371,988 - $802,889	-9,642 Reduced 67.65%	4,611 $228,000
Q4 2021 Feb 14, 2022	BUY	$75.47 - $135.88 $2,339 - $4,212	31 Added 0.22%	14,253 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $515,882 - $709,203	5,394 Added 61.1%	14,222 $1.52 Million
Q2 2021 Aug 12, 2021	BUY	$88.13 - $142.06 $37,631 - $60,659	427 Added 5.08%	8,828 $1.18 Million
Q1 2021 May 14, 2021	BUY	$105.48 - $207.97 $886,137 - $1.75 Million	8,401 New	8,401 $1.04 Million

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.